Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Synergy Pharmaceuticals Inc (NASDAQ:SGYP)

3.60
Delayed Data
As of May 27
 +0.10 / +2.86%
Today’s Change
2.50
Today|||52-Week Range
10.15
-36.51%
Year-to-Date
3 Small Biotechs Make Some Noise on a Quiet Day
May 27 / TheStreet.com - Paid Partner Content
Why Synergy Pharmaceuticals Is Spiking 13% Today
May 16 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close3.50
Today’s open3.50
Day’s range3.43 - 3.63
Volume2,037,715
Average volume (3 months)3,289,645
Market cap$647.2M
Dividend yield--
Data as of 4:00pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-8.82%
Earnings growth (this year)+16.89%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CLVSClovis Oncology Inc+0.26+1.58%
AIMTAimmune Therapeutics...0.000.00%
SCLNSciClone Pharmaceuti...+0.10+0.73%
EPZMEpizyme Inc+0.31+2.94%
Data as of 4:00pm ET, 05/27/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$0.00
Annual profit (last year)-$117.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Gary S. Jacob
Senior Vice President-
Clinical Operations
Laura Barrow
Corporate headquarters
New York, New York

Forecasts

Partner Offers

Search for Jobs